The Drug-Induced Respiratory Disease Website

Selpercatinib

Subclinical pulmonary infiltrates/ILD

(Fr. atteinte infraclinique). Interstitial or alveolar opacities detected incidentally on HRCT or if the BAL shows increased lymphocytes, neutrophils or eosinophils. PFTs typically yield normal results. See also under Iv

Publications

Ohkoshi H, Saiki M, Takahashi N, Homma K, Furuya S, Shimamura S, Omori C, Hoshino Y, Uchida Y, Ikemura S, Soejima K

A case of organizing pneumonia in rearranged during transfection fusion-positive lung adenocarcinoma treated with selpercatinib.

Thoracic cancer 2024 Jul 31;; — 2024 Jul 31

Diagnosing DIRD

Drug and radiation history

Drug singularity - Correct identification of the drug

Consistent timing of exposure v. onset of symptoms

Clinical, imaging, BAL, pathological pattern consistent with the specific drug

Careful exlusion of another cause

Remission of symptoms with removal of drug

Recurrence with rechallenge (rarely advisable)

Causality assessment

Diagnosing DIRD

Identify causative drugs

LATEST CHANGELOG

No activity has been recorded yet.

View full changelog